BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 20477307)

  • 1. MDR-/XDR-TB management: what it was, current standards and what is ahead.
    Monedero I; Caminero JA
    Expert Rev Respir Med; 2009 Apr; 3(2):133-45. PubMed ID: 20477307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multidrug-resistant and extensively drug-resistant tuberculosis: implications for the HIV epidemic and antiretroviral therapy rollout in South Africa.
    Andrews JR; Shah NS; Gandhi N; Moll T; Friedland G;
    J Infect Dis; 2007 Dec; 196 Suppl 3():S482-90. PubMed ID: 18181698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of HIV-infected patients with MDR- and XDR-TB in resource-limited settings.
    Scano F; Vitoria M; Burman W; Harries AD; Gilks CF; Havlir D
    Int J Tuberc Lung Dis; 2008 Dec; 12(12):1370-5. PubMed ID: 19017444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multidrug-resistant and extensively drug-resistant tuberculosis in the West. Europe and United States: epidemiology, surveillance, and control.
    Migliori GB; D'Arcy Richardson M; Sotgiu G; Lange C
    Clin Chest Med; 2009 Dec; 30(4):637-65, vii. PubMed ID: 19925959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tb drug resistance: is it really a threat to Africa?
    Nunn P; Zignol M; Jaramillo E; Wright A; Getahun H
    Ethiop Med J; 2007 Oct; 45(4):399-404. PubMed ID: 18326352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multidrug- and extensively drug-resistant tuberculosis in Africa and South America: epidemiology, diagnosis and management in adults and children.
    Schaaf HS; Moll AP; Dheda K
    Clin Chest Med; 2009 Dec; 30(4):667-83, vii-viii. PubMed ID: 19925960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extensively drug-resistant tuberculosis: are we learning from history or repeating it?
    Dukes Hamilton C; Sterling TR; Blumberg HM; Leonard M; McAuley J; Schlossberg D; Stout J; Huitt G
    Clin Infect Dis; 2007 Aug; 45(3):338-42. PubMed ID: 17599311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multidrug- and extensively drug-resistant TB in persons living with HIV.
    Matteelli A; Richardson MD; Sotgiu G; Centis R; Migliori GB
    Expert Rev Respir Med; 2009 Jun; 3(3):245-54. PubMed ID: 20477319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exogenous reinfection as a cause of multidrug-resistant and extensively drug-resistant tuberculosis in rural South Africa.
    Andrews JR; Gandhi NR; Moodley P; Shah NS; Bohlken L; Moll AP; Pillay M; Friedland G; Sturm AW;
    J Infect Dis; 2008 Dec; 198(11):1582-9. PubMed ID: 18847372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Practical and affordable measures for the protection of health care workers from tuberculosis in low-income countries.
    Harries AD; Maher D; Nunn P
    Bull World Health Organ; 1997; 75(5):477-89. PubMed ID: 9447782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genotypic diversity of extensively drug-resistant tuberculosis (XDR-TB) in South Africa.
    Mlambo CK; Warren RM; Poswa X; Victor TC; Duse AG; Marais E
    Int J Tuberc Lung Dis; 2008 Jan; 12(1):99-104. PubMed ID: 18173885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent advances in the diagnosis and treatment of multidrug-resistant tuberculosis.
    Ahmad S; Mokaddas E
    Respir Med; 2009 Dec; 103(12):1777-90. PubMed ID: 19660927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV infection and multidrug-resistant tuberculosis: the perfect storm.
    Wells CD; Cegielski JP; Nelson LJ; Laserson KF; Holtz TH; Finlay A; Castro KG; Weyer K
    J Infect Dis; 2007 Aug; 196 Suppl 1():S86-107. PubMed ID: 17624830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Tuberculosis and its control--lessons from the past and future prospect].
    Shimao T
    Kekkaku; 2005 Jun; 80(6):481-9. PubMed ID: 16130906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment outcomes for HIV-uninfected patients with multidrug-resistant and extensively drug-resistant tuberculosis.
    Kwon YS; Kim YH; Suh GY; Chung MP; Kim H; Kwon OJ; Choi YS; Kim K; Kim J; Shim YM; Koh WJ
    Clin Infect Dis; 2008 Aug; 47(4):496-502. PubMed ID: 18611154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TB deaths reach historic levels. International (global).
    AIDS Wkly Plus; 1996 Apr 8-15; ():14-6. PubMed ID: 12320054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extensively drug-resistant tuberculosis in sub-Saharan Africa: an emerging public-health concern.
    Jones KD; Hesketh T; Yudkin J
    Trans R Soc Trop Med Hyg; 2008 Mar; 102(3):219-24. PubMed ID: 18243260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emergence of Mycobacterium tuberculosis with extensive resistance to second-line drugs--worldwide, 2000-2004.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2006 Mar; 55(11):301-5. PubMed ID: 16557213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Global situation of TB and its control].
    Shimao T
    Kekkaku; 1999 Feb; 74(2):83-90. PubMed ID: 10191600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.